Internal Medicine, Endocrinology, Diabetes, & Metabolism · Normal, IL
NPI
1881840080
Since 2008
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
1302 Franklin Ave, Suite 1100
Normal, IL, 61761
Phone (309) 268-2727
Groups this clinician bills Medicare through
Medicare paid, 2024
$41K
923 services
Medicare patients, 2024
235
Average age 73
Drug cost, 2024
$1.6M
3,006 prescriptions
Company payments, 2025
$128
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Liza C Yambay Valiente was code 99214 (office e&m - established), 393 times for 197 patients. In total Liza C Yambay Valiente billed 923 services in 8 codes, and Medicare paid $41K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-06-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 393 | 197 | $63.97 | $25K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 239 | 165 | $11.65 | $2,783 |
| 95251 Test - Miscellaneous | Office | 193 | 65 | $24.64 | $4,755 |
| 99215 Office E&M - Established | Office | 41 | 31 | $105.79 | $4,337 |
| 99213 Office E&M - Established | Office | 26 | 25 | $50.86 | $1,322 |
| 99205 Office E&M - New | Office | 19 | 19 | $103.93 | $1,975 |
By year: 2022 $39K for 712 services; 2023 $39K for 683 services; 2024 $41K for 923 services.
Medicare prescription drug claims, 2024
In 2024, the drug Liza C Yambay Valiente prescribed most often to Medicare patients was Levothyroxine Sodium, with 407 prescriptions and refills. In total Liza C Yambay Valiente wrote 3,006 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 407 | 1,126 | 108 | $4,030 |
| Ozempic Semaglutide | 232 | 397 | 47 | $383K |
| Mounjaro Tirzepatide | 151 | 208 | 24 | $221K |
| Synthroid Levothyroxine Sodium | 147 | 334 | 36 | $11K |
| Farxiga Dapagliflozin Propanediol | 147 | 258 | 28 | $144K |
| Metformin Hcl Er Metformin Hcl | 146 | 376 | 39 | $2,126 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 146 | 300 | 38 | $14K |
| Jardiance Empagliflozin | 130 | 256 | 31 | $149K |
| Metformin Hcl Generic | 91 | 243 | 29 | $639 |
| Glipizide Er Glipizide | 82 | 231 | 24 | $1,061 |
| Trulicity Dulaglutide | 71 | 104 | 14 | $103K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 70 | 192 | 29 | $11K |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 69 | 147 | 18 | $108K |
| Pioglitazone Hcl Generic | 66 | 113 | 13 | $750 |
| Tresiba Flextouch U-200 Insulin Degludec | 48 | 99 | Under 11 | $67K |
Brand drugs: 1,844 claims; generic drugs: 952 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Liza C Yambay Valiente $128 ($128 in general payments such as food, travel and fees) from 2 companies. The largest payer was Insulet Corporation with $86.72.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.